Autologous Tumor-infiltrating Lymphocytes Therapy

tumor-infiltrating lymphocytes (TIL) therapy · Beijing 302 Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Tumor-infiltrating Lymphocytes Therapy, covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]

See pricing